Hospital Length of Stay and Readmission for Individuals Diagnosed With Schizophrenia: Are They Related?

Similar documents
Surgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report. May 2018

Mental Health Statistics, to

ICD-10 Reciprocal Billing File Technical Specifications Reference Guide for Ontario Hospitals

Health Quality Ontario

Defining High Users in Acute Care: An Examination of Different Approaches. Better data. Better decisions. Healthier Canadians.

Studies that have evaluated the relationship between length of stay and rate of readmission have reported contradictory results.

Making the Business Case for Long-Acting Injectables

Waiting Your Turn. Wait Times for Health Care in Canada, 2018 Report. by Bacchus Barua and David Jacques. with Antonia Collyer

Appendix B Fracture incidence and costs by province

Waiting Your Turn Wait Times for Health Care in Canada, 2017 Report

Exhibit I-1 Performance Measures. Numerator (general description only)

Mina Tadrous, Diana Martins, Zhan Yao, Kimberly Fernandes, Samantha Singh, Nikita Arora, David Juurlink, Muhammad Mamdani and Tara Gomes

Report from the National Diabetes Surveillance System:

Hospitalization for Mental Health Disorders 1

OUR TEAM OUR SPECIALIZED PROGRAMS

Case Mix and Funding. Health Data Users Day May 12, Greg Zinck Manager, Case Mix

Macrolides in community-acquired pneumonia and otitis media Canadian Coordinating Office for Health Technology Assessment

OxyContin in the 90 days prior to it being discontinued.

Measure #383 (NQF 1879): Adherence to Antipsychotic Medications For Individuals with Schizophrenia National Quality Strategy Domain: Patient Safety

Assisted Outpatient Treatment: Can it Reduce Criminal Justice Involvement of Persons with Severe Mental Illness?

Provincial Projections of Arthritis or Rheumatism, Special Report to the Canadian Rheumatology Association

Dementia Benchmarking Indicators Definitions and Data Sources Manual

THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION. Special Report: Opioid Admissions in Iowa August 2016

Supplementary Online Content

Health Canada. Santé Canada. Tuberculosis in Canada pre-release

Measure #383 (NQF 1879): Adherence to Antipsychotic Medications For Individuals with Schizophrenia National Quality Strategy Domain: Patient Safety

Physiotherapists in Canada, 2011 National and Jurisdictional Highlights

In the provision of mental health. Factors Associated With Involuntary Return to a Psychiatric Emergency Service Within 12 Months

Challenges to Recovery Following Early Psychosis: Implications of Recovery Rate and Timing

The Impact of Substance Use Disorders on Hospital Use

Implementing Rapid Response Teams (RRT) National Call September 13, 2007

Behavioural Symptoms of Dementia

by Sjoerd Sytema, Philip Burgess, and Michele Tansella Abstract

Organ Donation and Transplantation in Canada

Mentors on Discharge

Psychiatry A Recent Profile of the Profession

Canadian Organ Replacement Register Annual Report. Treatment of End-Stage Organ Failure in Canada, 2000 to 2009

Inpatient Psychiatric Length of Stay. And Readmission Rates. Katrina A. Drager

HTA Issue 32 September 2007

Canadian Organ Replacement Register Annual Report: Treatment of End-Stage Organ Failure in Canada, 2003 to 2012

GSK Medicine: Study Number: Title: Rationale: Study Period: Objectives: Indication: Study Investigators/Centers: Research Methods: Data Source

Prevalence and correlates of sedentary behaviour in an Atlantic Canadian populationbased. Cindy Forbes

Hospitalization due to pneumonia among Innu, Inuit and non-aboriginal communities, Newfoundland and Labrador, Canada

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

Impaired driving statistics

National Academy of Science July 17-18, 2018 Washington DC Larry Alphs, MD, PhD RESTRICTION OF TREATMENT QUALITY IN PRAGMATIC CLINICAL TRIALS

Performance Outcomes: Measure & Metric Details

An overview from CIHI reports related to seniors and aging.

ACEing Age Old Issues in the Care of Older Canadians

Table 1 Results of the 12-item General Health Questionnaire among caregivers who were or were not evacuated Not evacuated (N=46)

Quality Standards. Schizophrenia Care in the Community for Adults. October 2017

Geriatric Emergency Management PLUS Program Costing Analysis at the Ottawa Hospital

Comprehensive Research Plan: Inhaled corticosteroids + long-acting beta agonists (ICS+LABA) for the treatment of asthma

PROFILE AND PROJECTION OF DRUG OFFENCES IN CANADA. By Kwing Hung, Ph.D. Nathalie L. Quann, M.A.

A RCT of the Effects of Medication Adherence Therapy for People with Schizophrenia Specturm Disorders. Chien, Wai Tong; Mui, Jolene; Cheung, Eric

PART D HEALTH SERVICE UTILIZATION

Neurology. Neurology Profile

LAMA Products for the Treatment of COPD

2. How do different moderators (in particular, modality and orientation) affect the results of psychosocial treatment?

Achievements

Statewide Statistics and Key Findings 1

SPARRA Mental Disorder: Scottish Patients at Risk of Readmission and Admission (to psychiatric hospitals or units)

Mental health advocates, policy

Standard Operating Procedure: Early Intervention in Psychosis Access Times

Article. Trends in teen sexual behaviour and condom use. by Michelle Rotermann. Component of Statistics Canada Catalogue no X Health Reports

METHODS RESULTS. Supported by funding from Ortho-McNeil Janssen Scientific Affairs, LLC

TOTAL HIP AND KNEE REPLACEMENTS. FISCAL YEAR 2002 DATA July 1, 2001 through June 30, 2002 TECHNICAL NOTES

Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia

VISION PROBLEMS AMONG SENIORS Wayne J. Millar

Critical Care Medicine. Critical Care Medicine Profile

RESEARCH. What is already known about this subject

Adult Mental Health Services applicable to Members in the State of Connecticut subject to state law SB1160

Pharmacists in Canada A national survey of Canadians on their perceptions and attitudes towards pharmacists in Canada.

Schizophrenia Looking at the future

TRANSFUSION TRANSMITTED INJURIES SURVEILLANCE SYSTEM (TTISS): SUMMARY RESULTS. 1 P age

Cervical Cancer and Pap Test Utilisation in Manitoba

Estimating the volume of Contraband Sales of Tobacco in Canada

Unplanned Hospitalizations and Readmissions among Elderly Patients with GI Cancer

Falls Among Seniors Atlantic Canada June 2010 Types of Care Who We Are Our Vision

Colorectal Cancer Screening in Canada MONITORING & EVALUATION OF QUALITY INDICATORS RESULTS REPORT

Improved IPGM: Demonstrating the Value to both Patients and Hospitals

The Delivery of Radical Prostatectomy to Treat Men With Prostate Cancer

Why New Thinking is Needed for Older Adults across the Rehabilitation Continuum

The Value of Engagement in Substance Use Disorder (SUD) Treatment

Advancements in the Assessment of Medication Adherence: A Panel Discussion and Case Study. Finding Clarity in the Midst of Uncertainty

Geriatric Medicine. Geriatric Medicine Profile

ADHD and Education Survey March The Centre for ADHD Awareness, Canada

CHAPTER 4: Population-level interventions

Patterns and Cost of Health Care Transitions to Adult Care among Youth with Chronic Conditions in Ontario: A Population Based Cohort Study

Clinical Guidelines for the Pharmacologic Treatment of Schizophrenia

Discharge Abstract Database (DAD)/ CMG/Plx Data Quality. Re-abstraction Study

Ontario s Seniors Strategy: Where We Stand. Where We Need to Go

Management of Heart Failure: Review of the Performance Measures by the Performance Measurement Committee of the American College of Physicians

Abbreviated Class Review: Long-Acting Injectable Antipsychotics

Supply, Distribution and Migration of Canadian Physicians, 2010

Abbreviated Class Review: Long-Acting Injectable Antipsychotics

Diagnostic profile of inpatients as a determinant of length of stay in a general hospital psychiatric unit

Health Interventions in Ambulatory Cancer Care Centres DRAFT. Objectives. Methods

DIABETES MORTALITY IN NOVA SCOTIA FROM 1998 TO 2005: A DESCRIPTIVE ANALYSIS USING BOTH UNDERLYING AND MULTIPLE CAUSES OF DEATH

Optimizing implementation of fecal immunochemical testing in Ontario: A randomized controlled trial

Transcription:

April 17, 2008 Hospital Length of Stay and Readmission for Individuals Diagnosed With Schizophrenia: Are They Related? Summary Pan-Canadian data show relatively high rates of readmission and declining lengths of stay (LOS) among individuals hospitalized for mental illness. In this Analysis in Brief the relationship between hospital readmissions and LOS was examined for individuals aged 15 to 65 years who were diagnosed with schizophrenia in an initial episode of hospitalization. The investigation revealed that shorter initial hospital stays were related to higher rates of readmission. A relationship was also found between initial LOS and the number of days until readmission to hospital for individuals diagnosed with schizophrenia. Individuals whose initial hospital stays were longer had longer intervals between hospitalizations. This association was observed for short-, medium- and longer-term readmissions, but in the case of both the likelihood of readmission and time to readmission, the relationship was most pronounced for short-term (or 30-day) readmissions. Introduction In Canada, as in other countries, the rates of re-hospitalization or readmission for mental illness are very high relative to those for most other diseases. 1 3 Among mental illnesses, readmission rates for schizophrenia and psychotic disorders are among the highest. The chronic, highly debilitating and refractory nature of these disorders means that stabilization of an individual s condition regularly requires long stays in hospital. In light of this, the historical trend towards shorter hospital stays for mental illness prompts the question of whether less desirable outcomes, as reflected in unplanned hospital readmissions, can be expected. It might also be expected that as more time passes following a hospital stay, factors such as the availability of outpatient and community services would play a role in determining whether symptoms remain stable or there is a relapse that requires readmission to hospital.

This analysis, which looks at the relationship between LOS in an index (i.e. initial) episode of schizophrenia and readmission to hospital, is based on data from CIHI s Hospital Morbidity Database for fiscal years 2003 2004 and 2004 2005. The data are from general hospitals in all Canadian provinces and include individuals between the ages of 15 and 65 who were discharged from an acute care hospital with a primary diagnosis of schizophrenia. The time to readmission was calculated as the number of days between the initial discharge and a subsequent unplanned readmission for mental illness. Hospital readmission rates were examined for three time periods: short term, medium term, and longer term (1 to 30 days, 31 to 60 days and 61 to 90 days after the initial discharge, respectively). For each of these three time periods, readmissions were considered only for those individuals readmitted to hospital with a primary diagnosis of mental illness via an emergency department. In total, about 20 percent of these individuals were readmitted within 90 days of discharge, with an average time to readmission of 30.7 days. What are the characteristics of people diagnosed with schizophrenia who are readmitted to hospital? Short-term readmissions represented the largest single category, with almost 12% of individuals being readmitted within 30 days of discharge from hospital. This is also demonstrated in Figure 1, which allows for an examination of the hospital readmission rate for schizophrenia over a one-year period. After one week, more than 4% of individuals diagnosed with schizophrenia had been readmitted to hospital for a mental illness. The proportion rises most quickly within the first 30 days of follow-up, and then more gradually to about 28% at 180 days and about 38% after one year. 2

Figure 1 One-Year Hospital Readmissions for Individuals Diagnosed With Schizophrenia 45% Percent of Cases Readmitted 40% 35% 30% 25% 20% 15% 10% 5% 0% 4% 12% 17% 20% 28% 38% 0 20 40 60 80 100 120 140 160 180 200 220 240 260 280 300 320 340 360 Time to Readmission (Days) Note More detailed information on the distribution of readmissions is provided in Appendix A. Source Hospital Morbidity Database, Canadian Institute for Health Information, 2003 2004 and 2004 2005. Table 1 presents descriptive statistics for individuals diagnosed with schizophrenia who were tracked over one year. Readmissions for these individuals were examined for a follow-up period of 90 days after discharge and comparisons were made across the three readmission intervals, as well as for the entire 90-day interval. Since the readmission categories are mutually exclusive, individuals that are readmitted are not included in subsequent categories; therefore the analysis only considered the first readmission to hospital following the initial hospital stay in the period of interest. In each of the three categories, the average length of the initial hospital stay was shorter for individuals who were eventually readmitted than for those who were not. Also, among those who were readmitted, a longer average LOS for the initial hospital stay appeared to correspond to a longer time to readmission. Together, these findings suggest that individuals diagnosed with schizophrenia who had longer hospital stays were readmitted less often and spent greater time in the community prior to a readmission than those who had shorter hospital stays. 3

Table 1 Differences in Rate of Readmission, Age, Gender, Average LOS, Average Time to Readmission and Co-Occurring Substance Disorder by Category of Readmission for Individuals Diagnosed With Schizophrenia* N Short-Term Readmission? Percent Average Age Percent Female ALOS (Days) Average Time to Readmission (Days) % With Co-Occurring Substance Disorder Yes 2,102 11.9 36.7 43.0 15.3 12.4 18.8 No 15,549 88.1 38.0 41.4 19.2 -- 17.6 Total 17,651 100 Medium-Term Readmission? Yes 824 5.4 37.2 35.3 17.0 44.5 21.7 No 14,582 94.6 38.0 41.8 19.3 -- 17.4 Total 15,406 100 Longer-Term Readmission? Yes 608 4.2 37.4 43.8 18.1 75.5 15.1 No 13,894 95.8 38.0 41.7 19.4 -- 17.5 Total 14,502 100 Any Readmission Within 90 Days? Yes 3,534 20.0 36.9 41.3 16.2 30.7 18.9 No 14,117 80.0 38.1 41.7 19.3 -- 17.5 Total 17,651 100 Note * First readmission to hospital within the one-year period of observation only. Source Hospital Morbidity Database, Canadian Institute for Health Information, 2003 2004 and 2004 2005. 4

For individuals diagnosed with schizophrenia, is the length of an initial stay in hospital related to the likelihood of readmission? Statistical models were developed to examine the relationship between hospital LOS and readmission more thoroughly. i The models tested the relationship between LOS for each of the readmission categories while controlling for gender, comorbid substance disorder status, age and province of residence. The results suggest that, for each of the three readmission categories, longer initial hospital stays were associated overall with a lower likelihood of readmission. This association was most prominent for short-term readmissions (within 30 days) and was progressively diminished in the case of medium- and longer-term readmissions. Figure 2 presents the risk of readmission by length of initial hospital stay relative to a reference group of individuals who stayed in hospital for one week or less. In the case of those individuals readmitted within 30 days, for example, individuals whose initial hospital stays were between one and two weeks long were 21% less likely to be readmitted than those whose hospital stays were one week or less. This difference is amplified when those with the longest stays (seven weeks or more) are considered. Individuals whose initial hospital stays were seven weeks or longer were less than half as likely to be readmitted within 30 days when compared to those whose hospital stays were one week or less. For individuals diagnosed with schizophrenia who were readmitted within 31 to 60 days, those whose initial hospital stay was seven weeks or longer were 32% less likely to be readmitted when compared to those whose stays were one week or less. For individuals readmitted between 61 and 90 days following an initial discharge, the overall relationship is statistically significant but less clear. Those whose initial stay was seven weeks or longer were 19% less likely to be readmitted as compared to those whose stay was one week or less; however, those whose initial stay was 5 or 6 weeks had a slightly higher likelihood of readmission when compared to those who stayed 1 week or less. i. These are presented in greater detail in Appendix A. 5

Figure 2 Relative Risk of Readmission by LOS for Individuals Diagnosed With Schizophrenia 1.2 Relative Risk of Readmission 1.0 0.8 0.6 0.4 0.2 0.0 1 2 3 4 5 6 7+ Initial LOS (Weeks) Short-Term Readmission Medium-Term Readmission Longer-Term Readmission Source Hospital Morbidity Database, Canadian Institute for Health Information, 2003 2004 and 2004 2005. Taken collectively, comparisons across the categories of short-, medium-, and longerterm readmissions demonstrate that the relationship between readmission and LOS, although still statistically significant overall, was less clear as the follow-up period grew longer. The greater ambiguity in the association between LOS and longer-term readmissions may relate to the influence of a number of intervening factors. 6

For individuals diagnosed with schizophrenia, does the length of an initial stay in hospital influence the length of time before being readmitted? A subsequent analysis examined the relationship of hospital LOS and the number of days to readmission. The results, illustrated in Figure 3, suggest that for all individuals readmitted to hospital within 90 days, those with longer lengths of stay in the initial episode generally had longer periods between hospitalizations. Figure 3 LOS and Time to Readmission for Individuals Diagnosed With Schizophrenia and Readmitted Within 90 Days 40 Time to Readmission (Days) 35 30 25 20 15 10 1 2 3 4 5 6 7+ Initial LOS (Weeks) Source Hospital Morbidity Database, Canadian Institute for Health Information, 2003 2004 and 2004 2005. 7

As in the preceding analysis on the likelihood of readmission, the relationship between LOS and time to readmission is most prominent for individuals readmitted within 30 days. Figure 4 shows that individuals whose initial hospital stay lasted one week or less had the shortest time between initial discharge and 30-day readmission just over 11 days. By contrast, those individuals whose initial hospital stay lasted six weeks had, on average, more than 16 days between hospitalizations. Figure 4 LOS and Time to Readmission for Individuals Diagnosed With Schizophrenia and Readmitted Within 30 Days 17 Time to Readmission (Days) 16 15 14 13 12 11 10 9 1 2 3 4 5 6 7+ Initial LOS (Weeks) Source Hospital Morbidity Database, Canadian Institute for Health Information, 2003 2004 and 2004 2005. 8

Conclusions This analysis found a relationship between hospital LOS and readmission for mental illness among individuals diagnosed with schizophrenia in an initial episode. Those who were hospitalized longer in an index episode were less likely to be readmitted and, among those who were readmitted, stayed longer in the community. This association between longer initial hospital stays and more desirable outcomes has been reported elsewhere. 4 6 Further examination of this association may be instructive for the development and refinement of hospital and community treatment guidelines pertaining to schizophrenia, 5, 7, 8 as readmission to hospital is often suggestive of a relapse. For individuals hospitalized due to schizophrenia, an extended period of hospital care may be necessary to stabilize psychotic symptoms and to re-establish a regime of antipsychotic medication. In addition to the availability of community care and access to anti-psychotic medications, considering the length of hospital stay can assist clinicians in assessing the likelihood of costly readmission to hospital for individuals diagnosed with schizophrenia. 9, 10 These findings should be considered in the context of the decreasing duration of inpatient stays for mental illness that has been observed over the past few years. 1 The relationship between length of hospital stay and readmission appeared to be strongest when short-term readmissions were considered, and progressively less so for mediumand longer-term readmissions. This can reasonably be expected as a function of the proximity of the outcome and the episode of hospital care. 11 Later readmissions are probably more likely to reflect the influence of factors beyond inpatient hospitalization, such as effective transitional care, the availability of community and family supports, access to primary care, housing and continued access and adherence to prescribed medications. The data used for this analysis do not incorporate factors such as the type of inpatient care provided, the severity of the illness in the initial hospitalization or the availability of outpatient and community care. Further investigation considering such broader factors could provide more context on the relationship between LOS and readmission for individuals diagnosed with schizophrenia. The Ontario Mental Health Reporting System (OMHRS), a CIHI reporting system in place since October 2005 and specifically designed for inpatient mental health services, can now be used to further explore additional factors influencing LOS and readmission, among other outcomes, for a range of mental illnesses. 9

Appendix A Poisson Regression Poisson regression was used to examine the relationship between hospital readmission for individuals diagnosed with schizophrenia in an index episode and their LOS in an acute care hospital. The main effects model tested the relationship between LOS and the readmission rate controlling for age in initial episode, gender, the presence or absence of substance-related disorder as comorbid condition and province of residence. The time from discharge to readmission was used as an offset or regression variable with a constant coefficient of 1 for each observation. To corroborate the findings, the model was also tested using Cox proportional hazard regression, which yielded nearly identical results. Model Fit Model fit statistics were generated for the three models (short-, medium-, and longerterm readmission) examined in this analysis. All three models provided a significantly better fit to the data than respective null models. Additionally, a comparison of fit between the three models revealed that the model for short-term readmissions fit the data best, followed by the model for medium-term readmissions, and the model for longer-term readmissions had the poorest (but still acceptable) fit to the data. Main Effects The type 3 analysis in Table 2 provides the main effects of LOS on hospital readmissions while controlling for co-occurring substance disorder status, age, gender and province of residence for the three follow-up periods of interest. For all three follow-up periods (short-, medium-, and longer-term), LOS had a statistically significant relationship with the likelihood of readmission, while holding all the other variables constant. Furthermore, the effect of LOS was largest in the short-term model and progressively smaller in the medium- and longer-term models. Survival Distribution Function The data measure the number of days to readmission after discharge. The event of interest is readmission. To take censored cases into account, and to depict the overall readmission rate over a one-year period of observation, the Kaplan-Meier method was used to generate a general survival function. 10

Table 2 Likelihood Ratio Statistics of Type 3 Analyses for the Models Examining the Relationship Between LOS and Readmission for Individuals Diagnosed With Schizophrenia Variable DF Num. DF Denom. Chi-Square Probability Short-Term Readmission (Up to 30 Days After Discharge) LOS 6 17,631 122.47 <0.01 Co-Occurring Substance- Related Disorder 1 17,631 0.97 NS Age 4 17,631 28.65 <0.01 Gender 1 17,631 11.47 <0.01 Province of Residence * 7 17,631 17.10 <0.05 Medium-Term Readmission (31 to 60 Days After Discharge) LOS 6 15,386 39.80 <0.01 Co-Occurring Substance- Related Disorder 1 15,386 13.76 <0.01 Age 4 15,386 10.27 <0.05 Gender 1 15,386 23.84 <0.01 Province of Residence * 7 15,386 13.66 NS Longer-Term Readmission (61 to 90 Days After Discharge) LOS 6 14,482 15.09 <0.05 Co-Occurring Substance- Related Disorder 1 14,482 9.14 <0.01 Age 4 14,482 15.58 <0.01 Gender 1 14,482 4.81 <0.05 Province of Residence * 7 14,482 14.86 <0.05 Notes * Due to difficulties posed by their relatively small numbers, data for the four Atlantic provinces (Newfoundland and Labrador, New Brunswick, Nova Scotia and Prince Edward Island) were combined. DF Num. = Degrees of freedom in the numerator. DF Denom. = Degrees of freedom in the denominator. NS = Not significant. 11

Technical Notes Data Source The analyses presented here are based on data from CIHI s Hospital Morbidity Database for fiscal years 2003 2004 and 2004 2005. Inclusion Criterion Episodes of hospitalization were included if the most responsible diagnosis in an index episode was schizophrenia or a psychotic disorder. Hospitalization occurred in acute care inpatient hospitals, and cases were drawn from all provinces in Canada. Cases were tracked in the data for 1 year after an index discharge and were deemed readmitted if they were re-hospitalized for a mental illness via the emergency department within the given period. The analyses were based on data for individuals who were between the ages of 15 and 65 years at the time of the index episode of hospitalization. 12

References 1. Canadian Institute for Health Information, Hospital Mental Health Services in Canada 2004 2005 (Ottawa: CIHI, 2007). 2. Canadian Institute for Health Information, Hospital Mental Health Services in Canada 2003 2004 (Ottawa: CIHI, 2006). 3. N. Madi, H. Zhao and J. F. Li, Hospital Readmissions for Patients With Mental Illness in Canada, Healthcare Quarterly 10, 2 (2007): pp. 30 32. 4. R. Figueroa, J. Harman and J. Engberg, Use of Claims Data to Examine the Impact of Length of Inpatient Psychiatric Stay on Readmission Rate, Psychiatric Services 55, 5 (2004): pp. 560 565. 5. L. Appleby, D. J. Luchins, P. N. Desai, R. D. Gibbons, P. G. Janicak and R. Marks, Length of Inpatient Stay and Recidivism Among Patients With Schizophrenia, Psychiatric Services 47, 9 (1996): pp. 985 990. 6. L. Appleby, P. N. Desai, D. J. Luchins, R. D. Gibbons and D. R. Hedeker, Length of Stay and Recidivism in Schizophrenia: A Study of Public Psychiatric Hospital Patients, American Journal of Psychiatry 150, 1 (1993): pp. 72 76. 7. C. L. Caton and A. Gralnick, A Review of Issues Surrounding Length of Psychiatric Hospitalization, Hospital and Community Psychiatry 38, 8 (1987): pp. 858 863. 8. C. L. Caton, L. Mayers and A. Gralnick, The Long-Term Hospital Treatment of the Young Chronic Patient: Follow-Up Findings, Psychiatric Hospital 21, 1 (1990): pp. 25 30. 9. J. S. Lyons, M. T. O'Mahoney, S. I. Miller, J. Neme, J. Kabat and F. Miller, Predicting Readmission to the Psychiatric Hospital in a Managed Care Environment: Implications for Quality Indicators, American Journal of Psychiatry 154, 3 (1997): pp. 337 340. 10. J. Rabinowitz, P. Lichtenberg, Z. Kaplan, M. Mark, D. Nahon and M. Davidson, Rehospitalization Rates of Chronically Ill Schizophrenic Patients Discharged on a Regimen of Risperidone, Olanzapine, or Conventional Antipsychotics, American Journal of Psychiatry 158, 2 (2001): pp. 266 269. 11. J. Durbin, E. Lin, C. Layne and M. Teed, Is Readmission a Valid Indicator of the Quality of Inpatient Psychiatric Care?, Journal of Behavioral Health Services and Research 34, 2 (2007): pp. 137 150. 13